EnWave Secures Milestone Joint Development Agreement with GEA Lyophil to Advance REV Processing in Pharmaceutical Sector
While some new agreements that EnWave Corporation (CA:ENW – $1.60 & US:NWVCF – $1.23 & GER:E4U – €1.09) has achieved in recent years were arranged remarkably quickly, others require years of work to bring to fruition. The process is worthwhile nonetheless, as each new agreement contributes longer term growth potential. The evolution has been underway for several years to adapt […]
Read more